The Ne in the present study was maximal at Cz; the amplitude difference between ERPs to errors and to correct trials tested at this electrode (where the Ne was largest) was highly significant, F (1,14) = 129.9, p < .001, and also showed a trend for an interaction between group, session, and correctness, F (1,14) = 3.8, p = .073.
LBF adhesive also showed a trend similar to that of the FL bond; the released fluoride reduced from day 1 until day 28 ( p ≤0.001).
Analysis of adherence issues in relation to patient age showed a trend toward worse adherence to capecitabine therapy in the group of patients aged ≥80 years (hazard ratio =3.83; 95% confidence interval 2.48–5.91, P <0.001 versus 70–80 years group and versus <70 years group, chi-square test).
pylori status and demonstrated that the spontaneous negative conversion group showed a trend of more postoperative intestinal metaplasia compared to the persistent H. pylori group (36.7% [22/60] vs 16.3% [13/80], p=0.001).
Restricting analysis to only those who became pregnant, an additional Kaplan–Meier curve for TTP showed a trend of a longer, but less obvious, TTP among adolescent newlyweds with a thinner than larger preconceptional MUAC ( p = .001; Figure 3 ).
11 ) in the presence of FABP1 because the apparent K m for 4’-OH-diclofenac formation by CYP2C9 in the presence of hFABP1 (5.8 ± 1.5 μ M) only showed a trend for an increase ( P = 0.0011, 0.0729, 0.0416 for paired replicate experiments) when compared with in the absence of hFABP1 (1.4 ± 0.2 μ M) ( Supplemental Fig. 11 ; Table 2 ).
In contrast, the RABV-exposed group showed a trend towards lower frequencies of RABV-specific IFN-γ-secreting T cells at different timepoints with a significant decrease at M6 ( p = 0.0012) compared to the RABV-unexposed group (Fig. 5B ).
Both concentrations of FermCAE also showed a trend towards better antioxidant activity compared to respective concentrations of AQE, with a significant difference between the 2.5% extract groups ( p = 0.0014).
We performed Gene Set Enrichment Analysis (GSEA) on the differentially expressed genes and found that, compared with the NC group, the OGD + VK1 group showed a trend toward suppression of the cellular response to reactive oxygen species pathway ( p = 0.0017; p.adjust = 0.1457).
Enzymatic activity assays for SPHK1/2 showed a trend toward reduced activity ( Figure 1 D, p = 0.0018), indicating a decrease in both expression and activity of SPHK in human FRDA fibroblast cell lines.
The IVW analysis showed a trend-causing relationship between the brain cortex surficial area and succinylcarnitine levels ( β = 2.62 × 10 −05 , CI: 9.62 × 10 −06 to 4.24 × 10 −05 , p = 0.0019).
In addition, the number of days before maximum daily pollen occurrence showed a trend towards earlier pollen release during later years (R 2 = 0.287, p = 0.0019). 3.2.3.
Subgroup analysis by age showed a trend toward greater effect in <50-year-old participants ( p = 0.002) ( Supplementary Table S2 ).
The first class constantly maintained a higher and stable CF level, named the “Stable group”, with a proportion of 72.5%; The second class showed a trend of decline (Slope= -0.09, P = 0.002), was named the “Slow decline group”, with a proportion of 25.8%.
In contrast, the BP slope in the IH patients showed a trend towards a decrease with each hour (−0.3 mmHg/hr) during the first 24 hours, and this change was different from not only the same time period in controls (p=0.002, Figure 1 ), but also when compared to hours 25–44 in the IH patients (p=0.001).
Those who received chemotherapy also showed a trend for receiving tamoxifen (43.1% vs. 34.6%, P = 0.002).
LT also showed a trend of reducing the risk of MS in multinomial logistic regression (Model 1, OR = 0.203, 95% CI: 0.072 to 0.569, P = 0.002; Model 2, OR = 0.149, 95% CI: 0.056 to 0.399, P < 0.001).
Fluid therapy with Plasmalyte-148 showed a trend toward faster DKA resolution at 24 hours (69% vs. 36%; OR 4.24, 95% CI 1.68-10.72; p = 0.002) compared to sodium chloride, though the difference at 48 hours was not statistically significant [ 15 ].
The distribution of the dosing error among the referring health facilities (all the 13 [100%] patients from private hospitals, 66.7% from PHF, 60% from SHF, and 45.5% from THF) showed a trend of better performance ( p = 0.002) by the THFs.
In addition, larger tumor diameters (≥20 mm) showed a trend toward higher sensitivity (100% vs. 50%, p = 0.002) and concordance rate (100% vs. 80%, p = 0.002).
Nevertheless, the prevalence of dyslipidemia showed a trend of decreasing in boys (from 33.3 to 26.6%; P=0.002) and maintained in girls (from 28.4 to 30.2%; P=0.465), mainly due to a substantial decrease in hypo-HDL-cholesterolemia (9% reduction in boys, 5% reduction in girls).
Figure 4 displays all Charlson-Deyo comorbidity score comparisons; although increasing comorbidity scores showed a trend towards higher mortality risk, only the comparison of a score of 0 vs. ≥3 was statistically significant (HR: 6.70; 95% CI: 2.06−21.80; p = 0.002); other comparisons (e.g., 0 vs. 1, 0 vs. 2) were not.
Additionally, both cytokines showed a trend towards an association with disease severity (rho = 0.310, P = 0.002; rho = 0.188, P = 0.059, for IL-6 and IL-8, respectively).
The Wilcoxon signed rank test was not significant ( p =0.086), but showed a trend pointing into the same direction as the parametric mixed-effects model, which compares mean values ( p =0.002).
The incidence of scarring across the grades—grades I–IV (with distinctions based on lesion size)—showed a trend towards increased scarring with higher lesion grades, with rates ranging from 3.3% in grade I to 50.0% in grade IV lesions larger than 10 cm2 (p=0.002).